Cryopyrin-associated periodic syndrome

Results: 13



#Item
1Public Summary Document – November 2014 PBAC Meeting  5.1 ANAKINRA 100 mg/0.67 mL, 28 x 0.67 mL syringes;

Public Summary Document – November 2014 PBAC Meeting 5.1 ANAKINRA 100 mg/0.67 mL, 28 x 0.67 mL syringes;

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-16 01:05:14
2Rare diseases / Rheumatology / Immunosuppressants / Anakinra / Cryopyrin-associated periodic syndrome / Arthritis / Familial cold urticaria / Muckle–Wells syndrome / Neonatal onset multisystem inflammatory disease / Health / Medicine / Autoinflammatory syndromes

5.1 ANAKINRA 100 mg/0.67 mL, 28 x 0.67 mL syringes; Kineret®; A.Menarini Australia Pty Ltd. Purpose of Application

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-16 01:05:14
3OPEN  Citation: Cell Death and Disease[removed], e644; doi:[removed]cddis[removed] & 2013 Macmillan Publishers Limited All rights reserved[removed]www.nature.com/cddis

OPEN Citation: Cell Death and Disease[removed], e644; doi:[removed]cddis[removed] & 2013 Macmillan Publishers Limited All rights reserved[removed]www.nature.com/cddis

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2013-05-23 10:01:51
4Division: Pharmacy Services  Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Add to Reading List

Source URL: ahca.myflorida.com

Language: English - Date: 2014-08-11 09:14:02
5Division: Pharmacy Services  Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Add to Reading List

Source URL: www.ahca.myflorida.com

Language: English - Date: 2014-08-11 09:14:02
6Division: Pharmacy Services  Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Add to Reading List

Source URL: www.fdhc.state.fl.us

Language: English - Date: 2014-08-11 09:14:02
7Microsoft Word - CAPS_sospeso.doc

Microsoft Word - CAPS_sospeso.doc

Add to Reading List

Source URL: www.printo.it

Language: English - Date: 2013-05-27 08:25:13
8PRIOR AUTHORIZATION POLICY Ilaris® (canakinumab for subcutaneous [SC] injection Novartis)  To initiate a Coverage Review, Call[removed]

PRIOR AUTHORIZATION POLICY Ilaris® (canakinumab for subcutaneous [SC] injection Novartis) To initiate a Coverage Review, Call[removed]

Add to Reading List

Source URL: statehealthplan.state.nc.us

Language: English - Date: 2013-11-01 14:13:13
9PRIOR AUTHORIZATION POLICY Kineret® (anakinra for subcutaneous [SC] injection – Biovitrim) To Initiate a Coverage Review, Call[removed]OVERVIEW

PRIOR AUTHORIZATION POLICY Kineret® (anakinra for subcutaneous [SC] injection – Biovitrim) To Initiate a Coverage Review, Call[removed]OVERVIEW

Add to Reading List

Source URL: statehealthplan.state.nc.us

Language: English - Date: 2014-08-12 13:02:40
10Microsoft Word - Binder insert memo on letterhead E Sept11.doc

Microsoft Word - Binder insert memo on letterhead E Sept11.doc

Add to Reading List

Source URL: www.cpsp.cps.ca

Language: English - Date: 2012-10-22 14:28:42